IMAC Holdings, Inc.
IMAC Holdings, Inc., through its subsidiary, Ignite Proteomics LLC, provides proteomic product and precision medicine services based on activated protein analysis for the treatment of cancer in the United States. The company offers a reverse phase protein array (RPPA) platform, which can quantify protein signaling to support oncology clinical treatment decisions and biopharmaceutical drug development. IMAC Holdings, Inc. was founded in 2000 and is based in Franklin, Tennessee.
Stock Performance (90 Days)
Layoff History
Recent News
Other Medical Care Facilities Companies
View All →Frequently Asked Questions
Has IMAC Holdings, Inc. had layoffs?
How many employees does IMAC Holdings, Inc. have?
What industry is IMAC Holdings, Inc. in?
Is IMAC Holdings, Inc. a publicly traded company?
Where is IMAC Holdings, Inc. headquartered?
Disclaimer
Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.
This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.
Found an error? Report it here.